← Leaderboards
Ru Chen
Baylor College Of Medicine
$6,444,812
Attributed
$9,140,425
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,140,425 · 8
By mechanism
R01$7,102,407 · 3
R21$766,788 · 2
K07$649,506 · 1
UH3$328,995 · 1
UH2$292,729 · 1
Top collaborators
- Sheng Pan11 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Sharmila Anandasabapathy$9,395,698
- Sheng Pan$3,505,701
- David John Tweardy$14,168,425
- Lily S Cheng$664,938
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsProteomicsEarly DiagnosisCohortDetectionDiagnosisLesionBaseProteinsTechnologySamplingBioinformaticsMalignant Neoplasm Of PancreasBiological MarkersCancer DetectionTumor ProgressionPremalignantCase ControlEffective TherapyHigh RiskPancreasPancreatic JuiceResearch PersonnelResources
Grant awards (26)
Elucidating the role of gut microbiota in colitis-associated colorectal cancer$615,878
R01 · FY2025 · CA · contact PI
BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION$328,995
UH3 · FY2025 · CA · contact PI
Elucidating the role of gut microbiota in colitis-associated colorectal cancer$585,084
R01 · FY2024 · CA · contact PI
BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION$292,729
UH2 · FY2024 · CA · contact PI
Elucidating the role of gut microbiota in colitis-associated colorectal cancer$649,138
R01 · FY2023 · CA · contact PI
Biomarkers for Early Detection of Colorectal Cancer in Ulcerative Colitis$318,095
R01 · FY2022 · CA · contact PI
Biomarkers for Early Detection of Colorectal Cancer in Ulcerative Colitis$97,710
R01 · FY2021 · CA · contact PI
Biomarkers for Early Detection of Colorectal Cancer in Ulcerative Colitis$447,790
R01 · FY2020 · CA · contact PI
Biomarkers for Early Detection of Colorectal Cancer in Ulcerative Colitis$512,591
R01 · FY2019 · CA · contact PI
Early detection of pancreatic cancer in diabetics$534,119
R01 · FY2018 · CA · contact PI
Biomarkers for Early Detection of Colorectal Cancer in Ulcerative Colitis$496,407
R01 · FY2018 · CA · contact PI
Early detection of pancreatic cancer in diabetics$50,409
R01 · FY2018 · CA · contact PI
Early detection of pancreatic cancer in diabetics$587,611
R01 · FY2017 · CA · contact PI
Biomarkers for Early Detection of Colorectal Cancer in Ulcerative Colitis$460,311
R01 · FY2017 · CA · contact PI
Early detection of pancreatic cancer in diabetics$574,199
R01 · FY2016 · CA · contact PI
Early detection of pancreatic cancer in diabetics$572,954
R01 · FY2015 · CA · contact PI
Early detection of pancreatic cancer in diabetics$600,111
R01 · FY2014 · CA · contact PI
Mitochondria proteome of ulcerative colitis associated dysplasia$160,835
R21 · FY2013 · CA · contact PI
Mitochondria proteome of ulcerative colitis associated dysplasia$218,330
R21 · FY2012 · CA · contact PI
Pancreatic Juice Biomarker for Pancreatic Cancer$173,290
R21 · FY2012 · CA · contact PI
Pancreatic Juice Biomarker for Pancreatic Cancer$214,333
R21 · FY2011 · CA · contact PI
Protein biomarkers for detection of pancreatic cancer$118,794
K07 · FY2011 · CA · contact PI
Protein biomarkers for detection of pancreatic cancer$132,678
K07 · FY2010 · CA · contact PI
Protein biomarkers for detection of pancreatic cancer$132,678
K07 · FY2009 · CA · contact PI
Protein biomarkers for detection of pancreatic cancer$132,678
K07 · FY2008 · CA · contact PI
Protein biomarkers for detection of pancreatic cancer$132,678
K07 · FY2007 · CA · contact PI